Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 August 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Whole-genome sequencing impacts primary care and outcomes of healthy adults

This month's issue of the Annals of Internal Medicine examines the impact of whole-genome sequencing on the primary care and outcomes of healthy adult patients.

News image

Whole-genome sequencing in asymptomatic adults might prevent disease but increase health care use without clinical value.

Dr Jason Vassy and colleagues from Pennsylvania, USA described the effect on clinical care and outcomes of adding whole-genome sequencing to standardized family history assessment in primary care.

The team evaluated 9 primary care physicians, and 100 generally healthy patients recruited at ages 40 to 65 years.

Patients were randomly assigned to receive a family history report alone or in combination with an interpreted whole-genome sequencing report, which included monogenic disease risk results, carrier variants, pharmacogenomic associations, and polygenic risk estimates for cardiometabolic traits.

Each patient met with his or her primary care physicians to discuss the report.

The researchers obtained clinical outcomes and health care use through 6 months from medical records and audio-recorded discussions between primary care physicians and patients.

Only 4% had evidence of the phenotypes predicted by an monogenic disease risk results
Annals of Internal Medicine

Patients' health behavior changes were surveyed 6 months after receiving results.

A panel of clinician-geneticists rated the appropriateness of how primary care physicians managed MDR results.

The participants' mean age was 55 years, of which 58% were female.

The team found that 22% of family history + whole-genome sequencing patients had new monogenic disease risk results.

The research team observed that only 4% had evidence of the phenotypes predicted by an monogenic disease risk results.

Primary care physicians recommended new clinical actions for 16% of family history patients, and 34% of family history + whole-genome sequencing patients.

The team found that 30% and 41% and family history + whole-genome sequencing patients, respectively, reported making a health behavior change after 6 months.

Geneticists rated primary care physician management of 8 monogenic disease risk results as appropriate and 2 results as inappropriate.

Dr Vassy's team concludes, "Adding whole-genome sequencing to primary care reveals new molecular findings of uncertain clinical utility."

"Nongeneticist providers may be able to manage whole-genome sequencing results appropriately, but whole-genome sequencing may prompt additional clinical actions of unclear value."

Ann Intern Med 2017;167(3):159-169
10 August 2017

Go to top of page Email this page Email this page to a colleague

 22 August 2017 
Survival in patients with Lynch syndrome
 22 August 2017 
Improving the diagnostic accuracy of severe liver fibrosis in NAFLD
 22 August 2017 
New therapies to manage Hep B
 21 August 2017 
Treatments for chronic idiopathic constipation
 21 August 2017 
Improving medication adherence in IBD
 21 August 2017 
Ethnic disparities for chronic Hep C survival
 18 August 2017 
Proteomic analysis of IBD
 18 August 2017 
Pediatric intestinal failure
 18 August 2017 
Anti-TNF treatment and bowel resection in Crohn's
 17 August 2017 
Outcomes of ulcerative colitis patients undergoing pouch surgery
 17 August 2017 
Mortality in patients with asymptomatic pancreatic cystic neoplasms
 17 August 2017 
Survival after primary tumor resection in advanced colorectal cancer
 16 August 2017 
Assessment of seronegative villous atrophy
 16 August 2017 
Appendectomy and colectomy risk in ulcerative colitis
 16 August 2017 
Gluten sensitivity and celiac disease
 15 August 2017 
Infliximab and treatment failure during maintenance
 15 August 2017 
Genetic in idiopathic pancreatitis
 15 August 2017 
Genetic factors and tobacco in IBD
 14 August 2017 
Per oral endoscopic myotomy
 14 August 2017 
Early colonoscopy and symptomatic colorectal cancer
 14 August 2017 
Ethnic disparities and Hep C survival
 11 August 2017 
Ledipasvir and sofosbuvir in treatment-naïve Hep C
 11 August 2017 
EBV DNA to screen for nasopharyngeal cancer
 11 August 2017 
Direct acting antivirals and mixed cryoglobulinemia
 10 August 2017 
Routine preoperative laboratory tests for elective surgery
 10 August 2017 

Whole-genome sequencing in primary care

 10 August 2017 
Mortality in cirrhosis
 09 August 2017 
Anticoagulants in cirrhosis
 09 August 2017 
Low birthweight and pediatric NAFLD
 09 August 2017 
IBS with extraintestinal somatic and psychological symptoms
 08 August 2017 
Prior Barrett’s diagnosis and esophageal cancer survival
 08 August 2017 
Imaging index for fistulizing Crohn's
 08 August 2017 
Statin use after colon cancer
 07 August 2017 
Contraindications of biologic therapies in IBD
 07 August 2017 
Predicting clinical outcome in colorectal cancer
 07 August 2017 
Future burden of esophageal cancer
 04 August 2017 
Internet decision-making resources for ulcerative colitis surgery
 04 August 2017 
Distal findings and proximal colorectal neoplasia
 04 August 2017 
CT colonography vs flexible sigmoidoscopy
 03 August 2017 
Bloating and abdominal distension
 03 August 2017 
Predictors of colectomy in ulcerative colitis
 03 August 2017 
Treatment for sensitized transplant patients
 02 August 2017 
Preventing reactivation of Hep B
 02 August 2017 
Improving medication adherence in IBD
 02 August 2017 
Multiply recurrent C. difficile in the USA
 01 August 2017 
Coping with IBD
 01 August 2017 
Hepatocellular carcinoma in autoimmune hepatitis
 01 August 2017 
Anti-TNF treatment in Crohn's disease
 31 July 2017 
Global HCV incidence and mortality elimination targets
 31 July 2017 
Diagnosing GERD
 31 July 2017 
Diagnostic accuracy of severe liver fibrosis in patients with NAFLD
 28 July 2017 
Low FODMAP diet in IBS
 28 July 2017 
IBD patient–centered medical home
 28 July 2017 
Excluding NAFLD in the general population
 27 July 2017 
H. pylori infection and preeclampsia
 27 July 2017 
Colorectal cancer increases in developed and developing regions
 27 July 2017 
Anger in HIV-HCV co-infected patients
 26 July 2017 
Treating chronic pancreatitis
 26 July 2017 
Colorectal cancer screening
 26 July 2017 
Factors that influence H. pylori gastritis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us